Objective To describe empirical studies evaluating the impact of reference pricing (RP)
interventions in pharmaceutical markets in order to discuss the requirements for these …

Italian pharmaceutical policy has recently moved towards a “two lanes” approach, with
regulation differing according to a drug's patent status. This study analyses the Italian …

Background: Prescription drug expenditures in North America have nearly doubled in the
past 5 years, creating intense pressure for all public and private benefits managers and …

The Canada Health Act provides a framework for the Canadian health system and a
mechanism for federal healthcare funds to flow to the provinces. Presently, the Canada …

Türk toplumunun sağlık statüsünü yükseltmek sağlık sisteminin başlıca hedefidir. Bu amacı
gerçekleştirmek için, hakkaniyetin sağlanması, verimliliğin artırılması, hizmet kalitesinin ve …

Background: Formularies are used routinely for management of drug expenditures yet
evaluations of their impact remain rare. The objective of this study was to analyse the impact …

studies may have been excluded because the policy, misleadingly called “Reference-Based
Pricing,” sounds like a pricing policy. In fact, it is an insurance policy introduced in 1995 by …

Die Pharmaindustrie hat einen schlechten Ruf. In der letzten Zeit wurde auch in international
angesehenen medizinischen Fachzeitschriften oft Kritik an ihr geübt. Eine genaue Prüfung …

Turkey is a middle-income country on its course towards full EU membership. The most
recent and internationally comparable estimates from the National Health Account study …

The pharmaceutical industry has a bad image. Recently it has often also been criticised in
internationally well-known medical journals. An exact examination in the context of the …